-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
AKT is an important target related to a variety of cancers
In this study, scientists used tumor cell lines to screen out protein degradation agents that can target AKT
The researchers screened an AKT protein degradation agent called M21 and tested its anti-cancer activity in mouse models of breast and prostate cancer
▲M21 reduces tumor growth by 90% in a mouse model of prostate cancer (picture source: reference [1])
The researchers also evaluated which cancers are sensitive to this protein degrading agent